LLP® Femina- Vaginal Health

Product description

BV and VVC are the most prevalent vaginal infections, and many women experience them more than once in their lifetimes. Although these vaginal infections are generally treated with antibiotics, repeated exposure to antibiotics is associated with a high probability of complications, recurrence, and antibiotic resistance. The use of probiotics alone or in combination with antimicrobials positively alters the vaginal microflora and prevents vaginal infections. LLP® Vaginal Health is a strengthened combination of 6 probiotic strains, indicated mainly for women’s health. Promotes healthy vaginal microbiota, helps maintain healthy vaginal PH and conditions as recurrent  Bacterial vaginosis and candida.
Read more


Categories APIs (Active Pharmaceutical Ingredients)Probiotics
Sales markets Oceania; North America (USA, Canada); Africa; Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied from Israel

Products from other suppliers